PD-L1 as a urine biomarker in renal cell carcinoma: a case series and proof-of-concept study

Background: Renal cell carcinoma (RCC) is among the most lethal urologic malignancies once metastatic. Current treatment approaches for metastatic RCC (mRCC) involve immune checkpoint inhibitors (ICIs) that target the PD-L1/PD-1 axis. High PD-L1 expression in tumor tissue has been identified as a ne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reimold, Philipp (VerfasserIn) , Tosev, Georgi (VerfasserIn) , Kaczorowski, Adam (VerfasserIn) , Friedhoff, Jana (VerfasserIn) , Schwab, Constantin (VerfasserIn) , Schütz, Viktoria (VerfasserIn) , Görtz, Magdalena (VerfasserIn) , Panzer, Niklas (VerfasserIn) , Heller, Martina (VerfasserIn) , Aksoy, Cem (VerfasserIn) , Himmelsbach, Ruth (VerfasserIn) , Walle, Thomas (VerfasserIn) , Zschäbitz, Stefanie (VerfasserIn) , Jäger, Dirk (VerfasserIn) , Duensing, Anette (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Hohenfellner, Markus (VerfasserIn) , Duensing, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 March 2024
In: Diagnostics
Year: 2024, Jahrgang: 14, Heft: 7, Pages: 1-13
ISSN:2075-4418
DOI:10.3390/diagnostics14070741
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/diagnostics14070741
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2075-4418/14/7/741
Volltext
Verfasserangaben:Philipp Reimold, Georgi Tosev, Adam Kaczorowski, Jana Friedhoff, Constantin Schwab, Viktoria Schütz, Magdalena Görtz, Niklas Panzer, Martina Heller, Cem Aksoy, Ruth Himmelsbach, Thomas Walle, Stefanie Zschäbitz, Dirk Jäger, Anette Duensing, Albrecht Stenzinger, Markus Hohenfellner and Stefan Duensing

MARC

LEADER 00000caa a2200000 c 4500
001 1902473663
003 DE-627
005 20241205171849.0
007 cr uuu---uuuuu
008 240913s2024 xx |||||o 00| ||eng c
024 7 |a 10.3390/diagnostics14070741  |2 doi 
035 |a (DE-627)1902473663 
035 |a (DE-599)KXP1902473663 
035 |a (OCoLC)1475311478 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Reimold, Philipp  |e VerfasserIn  |0 (DE-588)1205514376  |0 (DE-627)1691191469  |4 aut 
245 1 0 |a PD-L1 as a urine biomarker in renal cell carcinoma  |b a case series and proof-of-concept study  |c Philipp Reimold, Georgi Tosev, Adam Kaczorowski, Jana Friedhoff, Constantin Schwab, Viktoria Schütz, Magdalena Görtz, Niklas Panzer, Martina Heller, Cem Aksoy, Ruth Himmelsbach, Thomas Walle, Stefanie Zschäbitz, Dirk Jäger, Anette Duensing, Albrecht Stenzinger, Markus Hohenfellner and Stefan Duensing 
264 1 |c 30 March 2024 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.09.2024 
520 |a Background: Renal cell carcinoma (RCC) is among the most lethal urologic malignancies once metastatic. Current treatment approaches for metastatic RCC (mRCC) involve immune checkpoint inhibitors (ICIs) that target the PD-L1/PD-1 axis. High PD-L1 expression in tumor tissue has been identified as a negative prognostic factor in RCC. However, the role of PD-L1 as a liquid biomarker has not yet been fully explored. Herein, we analyze urine levels of PD-L1 in mRCC patients before and after either ICI therapy or surgical intervention, as well as in a series of patients with treatment-naïve RCC. Patients and Methods: The mid-stream urine of patients with mRCC (n = 4) or treatment-naïve RCC, i.e., prior to surgery from two centers (cohort I, n = 49: cohort II, n = 29) was analyzed for PD-L1 by ELISA. The results from cohort I were compared to a control group consisting of patients treated for non-malignant urologic diseases (n = 31). In the mRCC group, urine PD-L1 levels were measured before and after tumor nephrectomy (n = 1) or before and after ICI therapy (n = 3). Exosomal PD-L1 in the urine was analyzed in selected patients by immunoblotting. Results: A strong decrease in urine PD-L1 levels was found after tumor nephrectomy or following systemic treatment with ICIs. In patients with treatment-naïve RCC (cohort I), urine PD-L1 levels were significantly elevated in the RCC group in comparison to the control group (median 59 pg/mL vs. 25.7 pg/mL, p = 0.011). PD-L1 urine levels were found to be elevated, in particular, in low-grade RCCs in cohorts I and II. Exosomal PD-L1 was detected in the urine of a subset of patients. Conclusion: In this proof-of-concept study, we show that PD-L1 can be detected in the urine of RCC patients. Urine PD-L1 levels were found to correlate with the treatment response in mRCC patients and were significantly elevated in treatment-naïve RCC patients. 
650 4 |a biomarker 
650 4 |a immunotherapy 
650 4 |a PD-L1 
650 4 |a RCC 
650 4 |a urine 
700 1 |a Tosev, Georgi  |e VerfasserIn  |4 aut 
700 1 |a Kaczorowski, Adam  |e VerfasserIn  |0 (DE-588)1062747550  |0 (DE-627)806827742  |0 (DE-576)420146318  |4 aut 
700 1 |a Friedhoff, Jana  |e VerfasserIn  |4 aut 
700 1 |a Schwab, Constantin  |d 1992-  |e VerfasserIn  |0 (DE-588)1106892291  |0 (DE-627)863243045  |0 (DE-576)474954269  |4 aut 
700 1 |a Schütz, Viktoria  |e VerfasserIn  |0 (DE-588)1183860021  |0 (DE-627)1663385335  |4 aut 
700 1 |a Görtz, Magdalena  |d 1992-  |e VerfasserIn  |0 (DE-588)1166813657  |0 (DE-627)1030681392  |0 (DE-576)510916600  |4 aut 
700 1 |a Panzer, Niklas  |e VerfasserIn  |0 (DE-588)1341886786  |0 (DE-627)1902476786  |4 aut 
700 1 |a Heller, Martina  |e VerfasserIn  |0 (DE-588)116209494X  |0 (DE-627)1025532414  |0 (DE-576)507144694  |4 aut 
700 1 |a Aksoy, Cem  |e VerfasserIn  |4 aut 
700 1 |a Himmelsbach, Ruth  |e VerfasserIn  |4 aut 
700 1 |a Walle, Thomas  |e VerfasserIn  |0 (DE-588)1218265876  |0 (DE-627)1733705457  |4 aut 
700 1 |a Zschäbitz, Stefanie  |d 1983-  |e VerfasserIn  |0 (DE-588)1037698827  |0 (DE-627)75589894X  |0 (DE-576)391727206  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Duensing, Anette  |e VerfasserIn  |0 (DE-588)1186091703  |0 (DE-627)1665366486  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Duensing, Stefan  |d 1967-  |e VerfasserIn  |0 (DE-588)1074044487  |0 (DE-627)830213007  |0 (DE-576)435550098  |4 aut 
773 0 8 |i Enthalten in  |t Diagnostics  |d Basel : MDPI, 2011  |g 14(2024), 7, Artikel-ID 741, Seite 1-13  |h Online-Ressource  |w (DE-627)718627814  |w (DE-600)2662336-5  |w (DE-576)365413917  |x 2075-4418  |7 nnas  |a PD-L1 as a urine biomarker in renal cell carcinoma a case series and proof-of-concept study 
773 1 8 |g volume:14  |g year:2024  |g number:7  |g elocationid:741  |g pages:1-13  |g extent:13  |a PD-L1 as a urine biomarker in renal cell carcinoma a case series and proof-of-concept study 
856 4 0 |u https://doi.org/10.3390/diagnostics14070741  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2075-4418/14/7/741  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240913 
993 |a Article 
994 |a 2024 
998 |g 1074044487  |a Duensing, Stefan  |m 1074044487:Duensing, Stefan  |d 910000  |d 910200  |d 50000  |e 910000PD1074044487  |e 910200PD1074044487  |e 50000PD1074044487  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 18  |y j 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |d 50000  |e 910000PH133862518  |e 910200PH133862518  |e 50000PH133862518  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 17 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |d 50000  |e 910000PS139606106  |e 912000PS139606106  |e 50000PS139606106  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 16 
998 |g 1186091703  |a Duensing, Anette  |m 1186091703:Duensing, Anette  |d 910000  |d 910200  |d 50000  |e 910000PD1186091703  |e 910200PD1186091703  |e 50000PD1186091703  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 15 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |d 50000  |e 910000PJ1032507535  |e 50000PJ1032507535  |k 0/910000/  |k 0/50000/  |p 14 
998 |g 1037698827  |a Zschäbitz, Stefanie  |m 1037698827:Zschäbitz, Stefanie  |d 910000  |d 910100  |d 50000  |e 910000PZ1037698827  |e 910100PZ1037698827  |e 50000PZ1037698827  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 13 
998 |g 1218265876  |a Walle, Thomas  |m 1218265876:Walle, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PW1218265876  |e 910100PW1218265876  |e 50000PW1218265876  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 12 
998 |g 116209494X  |a Heller, Martina  |m 116209494X:Heller, Martina  |d 910000  |d 910200  |e 910000PH116209494X  |e 910200PH116209494X  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 1341886786  |a Panzer, Niklas  |m 1341886786:Panzer, Niklas  |d 910000  |d 910200  |e 910000PP1341886786  |e 910200PP1341886786  |k 0/910000/  |k 1/910000/910200/  |p 8 
998 |g 1166813657  |a Görtz, Magdalena  |m 1166813657:Görtz, Magdalena  |d 910000  |d 910200  |d 50000  |e 910000PG1166813657  |e 910200PG1166813657  |e 50000PG1166813657  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 7 
998 |g 1183860021  |a Schütz, Viktoria  |m 1183860021:Schütz, Viktoria  |d 910000  |d 910200  |d 50000  |e 910000PS1183860021  |e 910200PS1183860021  |e 50000PS1183860021  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 6 
998 |g 1106892291  |a Schwab, Constantin  |m 1106892291:Schwab, Constantin  |d 910000  |d 912000  |d 50000  |e 910000PS1106892291  |e 912000PS1106892291  |e 50000PS1106892291  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 5 
998 |g 1062747550  |a Kaczorowski, Adam  |m 1062747550:Kaczorowski, Adam  |d 910000  |d 910200  |e 910000PK1062747550  |e 910200PK1062747550  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1205514376  |a Reimold, Philipp  |m 1205514376:Reimold, Philipp  |p 1  |x j 
999 |a KXP-PPN1902473663  |e 4579325257 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1902473663"],"doi":["10.3390/diagnostics14070741"]},"recId":"1902473663","relHost":[{"title":[{"title":"Diagnostics","title_sort":"Diagnostics","subtitle":"open access journal"}],"origin":[{"dateIssuedDisp":"2011-","publisher":"MDPI","dateIssuedKey":"2011","publisherPlace":"Basel"}],"pubHistory":["1.2011 -"],"note":["Gesehen am 28.05.2020"],"disp":"PD-L1 as a urine biomarker in renal cell carcinoma a case series and proof-of-concept studyDiagnostics","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"718627814","id":{"issn":["2075-4418"],"zdb":["2662336-5"],"eki":["718627814"]},"language":["eng"],"part":{"extent":"13","volume":"14","text":"14(2024), 7, Artikel-ID 741, Seite 1-13","issue":"7","pages":"1-13","year":"2024"}}],"name":{"displayForm":["Philipp Reimold, Georgi Tosev, Adam Kaczorowski, Jana Friedhoff, Constantin Schwab, Viktoria Schütz, Magdalena Görtz, Niklas Panzer, Martina Heller, Cem Aksoy, Ruth Himmelsbach, Thomas Walle, Stefanie Zschäbitz, Dirk Jäger, Anette Duensing, Albrecht Stenzinger, Markus Hohenfellner and Stefan Duensing"]},"physDesc":[{"extent":"13 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"30 March 2024"}],"note":["Gesehen am 13.09.2024"],"title":[{"subtitle":"a case series and proof-of-concept study","title_sort":"PD-L1 as a urine biomarker in renal cell carcinoma","title":"PD-L1 as a urine biomarker in renal cell carcinoma"}],"language":["eng"],"person":[{"display":"Reimold, Philipp","family":"Reimold","role":"aut","given":"Philipp"},{"display":"Tosev, Georgi","family":"Tosev","given":"Georgi","role":"aut"},{"role":"aut","given":"Adam","display":"Kaczorowski, Adam","family":"Kaczorowski"},{"display":"Friedhoff, Jana","family":"Friedhoff","role":"aut","given":"Jana"},{"display":"Schwab, Constantin","family":"Schwab","role":"aut","given":"Constantin"},{"display":"Schütz, Viktoria","family":"Schütz","given":"Viktoria","role":"aut"},{"given":"Magdalena","role":"aut","display":"Görtz, Magdalena","family":"Görtz"},{"family":"Panzer","display":"Panzer, Niklas","role":"aut","given":"Niklas"},{"family":"Heller","display":"Heller, Martina","given":"Martina","role":"aut"},{"given":"Cem","role":"aut","display":"Aksoy, Cem","family":"Aksoy"},{"display":"Himmelsbach, Ruth","family":"Himmelsbach","role":"aut","given":"Ruth"},{"role":"aut","given":"Thomas","family":"Walle","display":"Walle, Thomas"},{"role":"aut","given":"Stefanie","display":"Zschäbitz, Stefanie","family":"Zschäbitz"},{"role":"aut","given":"Dirk","family":"Jäger","display":"Jäger, Dirk"},{"given":"Anette","role":"aut","family":"Duensing","display":"Duensing, Anette"},{"role":"aut","given":"Albrecht","display":"Stenzinger, Albrecht","family":"Stenzinger"},{"display":"Hohenfellner, Markus","family":"Hohenfellner","given":"Markus","role":"aut"},{"role":"aut","given":"Stefan","display":"Duensing, Stefan","family":"Duensing"}]} 
SRT |a REIMOLDPHIPDL1ASAURI3020